Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Kerr

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
AIDS (London, England)|April 21, 2011
Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settingsKaren Schneider, Thanyawee Puthanakit, Stephen Kerr, et al.
Antiviral Therapy|September 14, 2010
Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in ThailandAnchalee Avihingsanon, Sharon R Lewin, Stephen Kerr, et al.
AIDS Patient Care and Stds|June 6, 2014
Comparison of adherence monitoring tools and correlation to virologic failure in a pediatric HIV clinical trialJintana Intasan, Torsak Bunupuradah, Saphonn Vonthanak, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2026
Diabetes and risk of significant fibrosis in adults with HIV and metabolic dysfunction-associated steatotic liver disease: a prospective cohort studyWin Min Han, Tanakorn Apornpong, Natthaya Chuaypen, et al.
Plos One|November 21, 2022
Bone mineral density among virologically suppressed Asians older than 50 years old living with and without HIV: A cross-sectional studyLalita Wattanachanya, Sarat Sunthornyothin, Tanakorn Apornpong, et al.
Journal of the International AIDS Society|May 20, 2025
No significant drug-drug interaction between oral TAF-based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT-3 studyAkarin Hiransuthikul, Narukjaporn Thammajaruk, Stephen Kerr, et al.
Journal of the International AIDS Society|April 8, 2025
Exploring potential drug-drug interactions between masculinizing hormone therapy and oral pre-exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open-label pharmacokinetic study in ThailandAkarin Hiransuthikul, Narukjaporn Thammajaruk, Stephen Kerr, et al.
Antiviral Therapy|April 28, 2017
Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trialAmanda H Yao, Cecilia L Moore, Poh Lian Lim, et al.
AIDS Care|May 30, 2019
Antiretroviral-naïve HIV-infected patients had lower bone formation markers than HIV-uninfected adultsLalita Wattanachanya, Jureeporn Jantrapakde, Anchalee Avihingsanon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2014
Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIV-positive womenNadia K Landolt, Nittaya Phanuphak, Sasiwimol Ubolyam, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
AIDS (London, England)|April 21, 2011
Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settingsKaren Schneider, Thanyawee Puthanakit, Stephen Kerr, et al.
Antiviral Therapy|September 14, 2010
Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in ThailandAnchalee Avihingsanon, Sharon R Lewin, Stephen Kerr, et al.
AIDS Patient Care and Stds|June 6, 2014
Comparison of adherence monitoring tools and correlation to virologic failure in a pediatric HIV clinical trialJintana Intasan, Torsak Bunupuradah, Saphonn Vonthanak, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2026
Diabetes and risk of significant fibrosis in adults with HIV and metabolic dysfunction-associated steatotic liver disease: a prospective cohort studyWin Min Han, Tanakorn Apornpong, Natthaya Chuaypen, et al.
Plos One|November 21, 2022
Bone mineral density among virologically suppressed Asians older than 50 years old living with and without HIV: A cross-sectional studyLalita Wattanachanya, Sarat Sunthornyothin, Tanakorn Apornpong, et al.
Journal of the International AIDS Society|May 20, 2025
No significant drug-drug interaction between oral TAF-based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT-3 studyAkarin Hiransuthikul, Narukjaporn Thammajaruk, Stephen Kerr, et al.
Journal of the International AIDS Society|April 8, 2025
Exploring potential drug-drug interactions between masculinizing hormone therapy and oral pre-exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open-label pharmacokinetic study in ThailandAkarin Hiransuthikul, Narukjaporn Thammajaruk, Stephen Kerr, et al.
Antiviral Therapy|April 28, 2017
Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trialAmanda H Yao, Cecilia L Moore, Poh Lian Lim, et al.
AIDS Care|May 30, 2019
Antiretroviral-naïve HIV-infected patients had lower bone formation markers than HIV-uninfected adultsLalita Wattanachanya, Jureeporn Jantrapakde, Anchalee Avihingsanon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2014
Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIV-positive womenNadia K Landolt, Nittaya Phanuphak, Sasiwimol Ubolyam, et al.
Pageof 10